Loading clinical trials...
Loading clinical trials...
The investigators purpose is to research the impact of the simultaneous use of a new dialysis membrane with higher permeability for medium and protein bound uraemic toxins (medium cut-off dialysis mem...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Medical Centre Ljubljana
Collaborators
NCT06422871 · End Stage Renal Disease, Hemodialysis Access Failure
NCT07567456 · Haemodialysis Patients, Blockage of Tunnelled Central Venous Access Device, and more
NCT06464497 · Obesity, Childhood, Diet, Healthy, and more
NCT07157397 · End Stage Renal Disease (ESRD), End Stage Kidney Disease (ESRD), and more
NCT06326905 · Quality of Life, Depression, and more
University Medical Centre Ljubljana
Ljubljana
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions